- Original Article
- Published:
Association of variants in genes involved in environmental chemical metabolism and risk of cryptorchidism and hypospadias
- Xian-Yang Qin 1,2 ,
- Yoshiyuki Kojima 3 ,
- Kentaro Mizuno 3 ,
- Katsuhiko Ueoka 4 ,
- Francesco Massart 5 ,
- Claudio Spinelli 6 ,
- Hiroko Zaha 1 ,
- Masahiro Okura 1 ,
- Jun Yoshinaga 2 ,
- Junzo Yonemoto 1 ,
- Kenjiro Kohri 3 ,
- Yutaro Hayashi 3 ,
- Tsutomu Ogata 7,8 &
- ...
- Hideko Sone 1
Journal of Human Genetics volume 57, pages 434–441 (2012)Cite this article
-
1589 Accesses
-
35 Citations
Abstract
We hypothesized that single-nucleotide polymorphisms (SNPs) of genes involved in environmental endocrine disruptors (EEDs) metabolism might influence the risk of male genital malformations. In this study, we explored for association between 384 SNPs in 15 genes (AHR, AHRR, ARNT, ARNT2, NR1I2, RXRA, RXRB, RXRG, CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP3A4, CYP17A1 and CYP19A1) and risk of cryptorchidism (CO) and hypospadias (HS) in 334 Japanese (JPN) males (141 controls, 95 CO and 98 HS) and 187 Italian (ITA) males (129 controls and 58 CO). In the JPN study group, five SNPs from ARNT2 (rs2278705 and rs5000770), CYP1A2 (rs2069521), CYP17A1 (rs4919686) and NR1I2 (rs2472680) were significantly associated at both allelic and genotypic levels with risk of at least one genital malformation phenotype. In the ITA study group, two SNPs in AHR (rs3757824) and ARNT2 (rs1020397) were significantly associated with risk of CO. Interaction analysis of the positive SNPs using multifactor dimensionality reduction demonstrated that synergistic interaction between rs2472680, rs4919686 and rs5000770 had 62.81% prediction accuracy for CO (P=0.011) and that between rs2069521 and rs2278705 had 69.98% prediction accuracy for HS (P=0.001) in JPN population. In a combined analysis of JPN and ITA population, the most significant multi-locus association was observed between rs5000770 and rs3757824, which had 65.70% prediction accuracy for CO (P=0.055). Our findings indicate that genetic polymorphisms in genes involved in EED metabolism are associated with risk of CO and HS.
Similar content being viewed by others
Association between the CYP1A1 MspI polymorphism and risk of head and neck cancer: a meta-analysis
Association between CYP2E1 polymorphisms and colorectal cancer risk: a systematic review and meta-analysis
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Vidaeff, A.C., Sever, L.E. In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod. Toxicol. 20, 5–20 (2005).
Martin, O.V., Shialis, T., Lester, J.N., Scrimshaw, M.D., Boobis, A.R., Voulvoulis, N. Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis. Environ. Health. Perspect. 116, 149–157 (2008).
Carbone, P., Giordano, F., Nori, F., Mantovani, A., Taruscio, D., Lauria, L. et al. The possible role of endocrine disrupting chemicals in the aetiology of cryptorchidism and hypospadias: a population-based case-control study in rural Sicily. Int. J. Androl. 30, 3–13 (2007).
Fernandez, M.F., Olmos, B., Granada, A., Lopez-Espinosa, M.J., Molina-Molina, J.M., Fernandez, J.M. et al. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environ. Health. Perspect. 115 (Suppl 1), 8–14 (2007).
Morales-Suarez-Varela, M.M., Toft, G.V., Jensen, M.S., Ramlau-Hansen, C., Kaerlev, L., Thulstrup, A.M. et al. Parental occupational exposure to endocrine disrupting chemicals and male genital malformations: a study in the danish national birth cohort study. Environ. Health 10, 3 (2011).
Sasaki, G., Ogata, T., Ishii, T., Kosaki, K., Sato, S., Homma, K. et al. Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. J. Clin. Endocrinol. Metab. 88, 3431–3436 (2003).
Watanabe, M., Yoshida, R., Ueoka, K., Aoki, K., Sasagawa, I., Hasegawa, T. et al. Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities. Hum. Reprod. 22, 1279–1284 (2007).
Willingham, E., Baskin, L.S. Candidate genes and their response to environmental agents in the etiology of hypospadias. Nat. Clin. Pract. Urol. 4, 270–279 (2007).
Foresta, C., Zuccarello, D., Garolla, A., Ferlin, A. Role of hormones, genes, and environment in human cryptorchidism. Endocr. Rev. 29, 560–580 (2008).
Kojima, Y., Mizuno, K., Kohri, K., Hayashi, Y. Advances in molecular genetics of cryptorchidism. Urology 74, 571–578 (2009).
Kojima, Y., Kohri, K., Hayashi, Y. Genetic pathway of external genitalia formation and molecular etiology of hypospadias. J. Pediatr. Urol. 6, 346–354 (2010).
van der Zanden, L.F., van Rooij, I.A., Feitz, W.F., Vermeulen, S.H., Kiemeney, L.A., Knoers, N.V. et al. Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation? J. Clin. Endocrinol. Metab. 95, 2384–2390 (2010).
Kurahashi, N., Sata, F., Kasai, S., Shibata, T., Moriya, K., Yamada, H. et al. Maternal genetic polymorphisms in CYP1A1, GSTM1 and GSTT1 and the risk of hypospadias. Mol. Hum. Reprod. 11, 93–98 (2005).
Johansson, I., Ingelman-Sundberg, M. Genetic polymorphism and toxicology—with emphasis on cytochrome p450. Toxicol. Sci. 120, 1–13 (2011).
Ban, S., Sata, F., Kurahashi, N., Kasai, S., Moriya, K., Kakizaki, H. et al. Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias. Hum. Reprod. 23, 1466–1471 (2008).
Waxman, D.J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369, 11–23 (1999).
Harper, P.A., Wong, J.Y., Lam, M.S., Okey, A.B. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 141, 161–187 (2002).
Sato, H., Ishida, S., Toda, K., Matsuda, R., Hayashi, Y., Shigetaka, M. et al. New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet. Curr. Drug Discov. Technol. 2, 89–98 (2005).
Ritchie, M.D., Hahn, L.W., Roodi, N., Bailey, L.R., Dupont, W.D., Parl, F.F. et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69, 138–147 (2001).
Lou, X.Y., Chen, G.B., Yan, L., Ma, J.Z., Zhu, J., Elston, R.C. et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 80, 1125–1137 (2007).
Binh, T.Q., Nakahori, Y., Hien, V.T., Khan, N.C., Lam, N.T., Mai le, B. et al. Correlations between genetic variance and adiposity measures, and gene ×ばつ gene interactions for obesity in postmenopausal Vietnamese women. J. Genet. 90, 1–9 (2011).
Sanderson, J.T. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol. Sci. 94, 3–21 (2006).
Hirose, K., Morita, M., Ema, M., Mimura, J., Hamada, H., Fujii, H. et al. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol. Cell. Biol. 16, 1706–1713 (1996).
Sekine, H., Mimura, J., Yamamoto, M., Fujii-Kuriyama, Y. Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses. J. Biol. Chem. 281, 37507–37516 (2006).
Hankinson, O. Why does ARNT2 behave differently from ARNT? Toxicol. Sci. 103, 1–3 (2008).
Hill, A.J., Heiden, T.C., Heideman, W., Peterson, R.E. Potential roles of Arnt2 in zebrafish larval development. Zebrafish 6, 79–91 (2009).
Barrow, L.L., Wines, M.E., Romitti, P.A., Holdener, B.C., Murray, J.C. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2): structure, gene mapping, polymorphisms, and candidate evaluation for human orofacial clefts. Teratology 66, 85–90 (2002).
Skakkebaek, N.E., Rajpert-De Meyts, E., Main, K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972–978 (2001).
Jorgensen, N., Meyts, E.R., Main, K.M., Skakkebaek, N.E. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis. Int. J. Androl. 33, 298–303 (2010).
Yoshimura, K., Hanaoka, T., Ohnami, S., Kohno, T., Liu, Y., Yoshida, T. et al. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples. J. Hum. Genet. 48, 654–658 (2003).
Ikeda, S., Sasazuki, S., Natsukawa, S., Shaura, K., Koizumi, Y., Kasuga, Y. et al. Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am. J. Gastroenterol. 103, 1476–1487 (2008).
Sharp, L., Cardy, A.H., Cotton, S.C., Little, J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am. J. Epidemiol. 160, 729–740 (2004).
Chen, Y., Gammon, M.D., Teitelbaum, S.L., Britton, J.A., Terry, M.B., Shantakumar, S. et al. Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 29, 766–771 (2008).
Wang, J.F., Chou, K.C. Molecular modeling of cytochrome P450 and drug metabolism. Curr. Drug. Metab. 11, 342–346 (2010).
Wright, J.L., Kwon, E.M., Lin, D.W., Kolb, S., Koopmeiners, J.S., Feng, Z. et al. CYP17 polymorphisms and prostate cancer outcomes. Prostate 70, 1094–1101 (2010).
Holmes, N.M., Miller, W.L., Baskin, L.S. Lack of defects in androgen production in children with hypospadias. J. Clin. Endocrinol. Metab. 89, 2811–2816 (2004).
Low, Y.L., Dunning, A.M., Dowsett, M., Folkerd, E., Doody, D., Taylor, J. et al. Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESR1 and NR1I2 gene variants. Cancer Epidemiol. Biomarkers Prev. 16, 1009–1016 (2007).
Long, J.R., Egan, K.M., Dunning, L., Shu, X.O., Cai, Q., Cai, H. et al. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet. Genomics 16, 237–243 (2006).
Wang, H., Yamamoto, J.F., Caberto, C., Saltzman, B., Decker, R., Vogt, T.M. et al. Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis 32, 203–209 (2011).
Clemons, M., Goss, P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 344, 276–285 (2001).
Syme, M.R., Paxton, J.W., Keelan, J.A. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet. 43, 487–514 (2004).
Yoshida, R., Fukami, M., Sasagawa, I., Hasegawa, T., Kamatani, N., Ogata, T. Association of cryptorchidism with a specific haplotype of the estrogen receptor alpha gene: implication for the susceptibility to estrogenic environmental endocrine disruptors. J. Clin. Endocrinol. Metab. 90, 4716–4721 (2005).
Galan, J.J., Guarducci, E., Nuti, F., Gonzalez, A., Ruiz, M., Ruiz, A. et al. Molecular analysis of estrogen receptor alpha gene AGATA haplotype and SNP12 in European populations: potential protective effect for cryptorchidism and lack of association with male infertility. Hum. Reprod. 22, 444–449 (2007).
Acknowledgements
This study was partly supported by the Environment Research and Technology Development Fund from the Ministry of the Environment, Japan, and by a grant for Research on Risk on Chemical Substances (H20-004) from the Ministry of Health, Labor, and Welfare of Japan. There is no other source of funding that has supported this study. We thank Dr Rie Taniguchi (Institute of Medicinal Molecular Design Inc., Tokyo, Japan) for technical support in gene target selection with KeyMolnet.
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Qin, XY., Kojima, Y., Mizuno, K. et al. Association of variants in genes involved in environmental chemical metabolism and risk of cryptorchidism and hypospadias. J Hum Genet 57, 434–441 (2012). https://doi.org/10.1038/jhg.2012.48
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2012.48
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
This article is cited by
-
Interaction between CYP1A1/CYP17A1 polymorphisms and parental risk factors in the risk of hypospadias in a Chinese population
- Yaping Mao
- Kang Zhang
- Mingyue Ma
Scientific Reports (2019)
-
Single-nucleotide and copy-number variance related to severity of hypospadias
- Neetu Singh
- Devendra Kumar Gupta
- Arun Kumar Singh
Pediatric Surgery International (2018)
-
Risk factors for cryptorchidism
- Jason K. Gurney
- Katherine A. McGlynn
- Diana Sarfati
Nature Reviews Urology (2017)
-
Effects on normalized testicular atrophy index (TAIn) in cryptorchid infants treated with GnRHa pre and post-operative vs surgery alone: a prospective randomized trial and long-term follow-up on 62 cases
- Claudio Spinelli
- Silvia Strambi
- Francesco Bianco
Pediatric Surgery International (2014)
-
A Commentary on Association of variants in genes involved in environmental chemical metabolism and risk of cryptorchidism and hypospadias
- Maki Fukami
Journal of Human Genetics (2012)